1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with 1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine in 34 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine) | Trials (1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine) | Recent Studies (post-2010) (1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 39 | 0 | 1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 26 (76.47) | 18.7374 |
| 1990's | 5 (14.71) | 18.2507 |
| 2000's | 2 (5.88) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (2.94) | 2.80 |
| Authors | Studies |
|---|---|
| Dive, C; Watson, JV; Workman, P | 1 |
| Clarke, FM; Cock, I; Orozco, C; Perkins, AV | 1 |
| Bereziat, G; Chachaty, C; Olivier, JL; Wolf, C | 1 |
| Hayashi, M; Kimura, J; Nomura, H; Oh-Ishi, S; Tsushima, S | 1 |
| Evstigneeva, RP; Gordeev, KIu; Serebrennikova, GA | 1 |
| Honey, AC; Lad, N; Tuffin, DP | 1 |
| Akkerman, JW; Hasselaar, P; Kloprogge, E | 1 |
| Clarke, FM; Orozco, C; Perkins, T | 1 |
| Davey, P; Dyer, RL; Lunt, DO; Tuffin, DP; Wade, PJ | 1 |
| Cervoni, P; Goldstein, BM; Herzlinger, H; Lai, FM; Quirk, GJ | 1 |
| Kamitani, T; Katamoto, M; Katsuta, K; Kikuchi, H; Kumada, S; Ono, T; Tatsumi, M | 1 |
| Hillmar, I; Zöllner, N | 1 |
| Chap, H; Douste-Blazy, L; Mauco, G | 1 |
| Gorman, RR; Hopkins, NK; Lin, AH | 1 |
| Cervoni, P; Lai, FM; Shepherd, CA; Wissner, A | 1 |
| Ostermann, G; Thielmann, K; Till, U | 1 |
| Hadding, U; Hartung, HP; Parnham, MJ; Winkelman, J | 1 |
| Archer, CB; MacDonald, DM; Morley, J; Page, CP; Paul, W | 1 |
| Cervoni, P; Herzlinger, HE; Lai, FM; Tanikella, TK | 1 |
| Haslam, RJ; Williams, KA | 1 |
| Hajdu, J; Hoffman, DR; Snyder, F | 1 |
| Jacquemin, C; Touqui, L; Vargaftig, BB | 1 |
| Baumgartner, HR; Hadváry, P | 1 |
| Benveniste, J; Czarnetzki, BM | 1 |
| Alonso, F; Alvarez, V; Egido, J; Iñarrea, P; Sánchez-Crespo, M | 1 |
| Ashley, CJ; Sheppard, H; Tsien, WH | 1 |
| Benveniste, J; Borrel, MC; Coeffier, E; Convert, O; Godfroid, JJ; Heymans, F; Michel, E; Tence, M; Wichrowski, B | 1 |
| Benveniste, J; Godfroid, JJ; Heymans, F; Michel, E; Redeuilh, C; Steiner, E | 1 |
| Barnes, PJ; Giembycz, MA; Ring, PC; Seldon, PM | 1 |
| Callais, F; Festy, B; Kuenemann-Migeot, C; Momas, I | 1 |
| Arese, M; Bargnani, C; Bussolino, F; Callea, L; Orlandini, A; Priori, A | 1 |
| Fukushima, A; Igarashi, A; Okumura, N; Sumi, T; Ueno, H; Yamagishi, T | 1 |
| Baenziger, JE; Bennett, SA; Carswell, CL; Harris, CS; Ryan, SD | 1 |
| Kim, Y; Stanley, D | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine
| Article | Year |
|---|---|
Eicosanoid Signaling in Insect Immunology: New Genes and Unresolved Issues.
Topics: Animals; Arachidonic Acid; Eicosanoids; Fatty Acid Desaturases; Hemocytes; Insecta; Lipoxygenase; Mammals; Phospholipases A2; Platelet Activating Factor; Prostaglandin-Endoperoxide Synthases; Signal Transduction | 2021 |
33 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and 1-0-octadecyl 2-0-acetyl sn-glycero-3-phosphorylcholine
| Article | Year |
|---|---|
Multiparametric flow cytometry of the modulation of tumor cell membrane permeability by developmental antitumor ether lipid SRI 62-834 in EMT6 mouse mammary tumor and HL-60 human promyelocytic leukemia cells.
Topics: Animals; Antineoplastic Agents; Azepines; Cell Division; Cell Membrane Permeability; Flow Cytometry; Furans; Humans; Hydrogen-Ion Concentration; Leukemia, Promyelocytic, Acute; Mammary Neoplasms, Animal; Mice; Phospholipid Ethers; Platelet Activating Factor; Time Factors; Triazoles; Tumor Cells, Cultured | 1991 |
Partial characterization of the PAF-induced soluble factors which mimic the activity of 'early pregnancy factor'.
Topics: Animals; Biological Factors; Calcimycin; Chaperonin 10; Diethylcarbamazine; Masoprocol; Mice; Peptides; Platelet Activating Factor; Pregnancy Proteins; Solubility; Spleen; Stimulation, Chemical; Suppressor Factors, Immunologic; Vasodilator Agents | 1990 |
Influence of PAF-acether on lecithin-oriented multibilayers monitored by ESR: interaction of PAF-acether with cholesterol.
Topics: Cholesterol; Electron Spin Resonance Spectroscopy; Lipid Bilayers; Phosphatidylcholines; Platelet Activating Factor; Spin Labels | 1989 |
Characterization of the activity of a platelet activating factor antagonist, CV-3988.
Topics: Alprazolam; Animals; Autacoids; Blood Pressure; Capillary Permeability; Dose-Response Relationship, Drug; Male; Phospholipid Ethers; Platelet Activating Factor; Rabbits; Rats; Rats, Inbred Strains; Skin; Thiazoles | 1987 |
[Synthesis of 1-(1-alkenyl)-2-acetyl-sn-glycero-3-phosphocholines, the aldehyded analogs of platelet activating factor].
Topics: Chemical Phenomena; Chemistry; Humans; In Vitro Techniques; Platelet Activating Factor; Platelet Aggregation | 1987 |
Effect of indomethacin and dazoxiben on intravascular platelet aggregation in the anaesthetized rabbit.
Topics: Adenosine Diphosphate; Animals; Collagen; Dose-Response Relationship, Drug; Imidazoles; Indomethacin; Male; Platelet Activating Factor; Platelet Aggregation; Rabbits; Thrombin; Thromboxane B2 | 1986 |
PAF-acether (1-O-hexadecyl/octadecyl-2-acetyl-sn-glycero-3-phosphocholine)-induced fibrinogen binding to platelets depends on metabolic energy.
Topics: Blood Platelets; Cyanides; Deoxyglucose; Energy Metabolism; Fibrinogen; Humans; Platelet Activating Factor; Platelet Aggregation; Protein Binding; Stimulation, Chemical | 1986 |
Platelet-activating factor induces the expression of early pregnancy factor activity in female mice.
Topics: Animals; Chaperonin 10; Estrus; Female; Immunosuppressive Agents; Peptides; Platelet Activating Factor; Pregnancy Proteins; Suppressor Factors, Immunologic | 1986 |
Specific binding of [3H]-1-O-octadecyl Paf-acether to washed human platelets.
Topics: Adenosine Triphosphate; Binding Sites; Binding, Competitive; Blood Platelets; Calcium; Half-Life; Humans; Kinetics; Platelet Activating Factor; Platelet Aggregation; Platelet Count; Tritium | 1985 |
Evidence for the lack of interaction between (+/-)-1-O-octadecyl-2-acetylglyceryl-3-phosphorylcholine and alpha-adrenoceptors in vivo and in vitro.
Topics: Angiotensin II; Animals; Blood Pressure; Cats; Epinephrine; In Vitro Techniques; Male; Nictitating Membrane; Norepinephrine; Phentolamine; Platelet Activating Factor; Rats; Rats, Inbred SHR; Receptors, Adrenergic, alpha; Splanchnic Circulation | 1984 |
Mechanism(s) of the hypotensive effect of synthetic 1-O-octadecyl-2-O-acetyl-glycero-3-phosphorylcholine.
Topics: Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Atrial Function; Blood Pressure; Bronchi; Decerebrate State; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Myocardial Contraction; Perfusion; Platelet Activating Factor; Platelet Aggregation; Rats; Rats, Inbred Strains; Vasodilation; Vasodilator Agents | 1984 |
Saturated and unsaturated 1-0-alkyl-2-0-acetoyl-sn-glycero-3-phosphocholines and 2-lyso derivatives from ratfish liver oil. Effect on adenosine 3':5'-cyclic monophosphate concentration in hepatocyte suspensions.
Topics: Animals; Cells, Cultured; Cyclic AMP; Fish Oils; In Vitro Techniques; Liver; Platelet Activating Factor; Rats; Rats, Inbred Strains; Time Factors | 1983 |
Platelet activating factor (PAF-acether) promotes an early degradation of phosphatidylinositol-4,5-biphosphate in rabbit platelets.
Topics: Animals; Blood Platelets; Kinetics; Phosphatidylinositol 4,5-Diphosphate; Phosphatidylinositols; Platelet Activating Factor; Platelet Aggregation; Rabbits | 1983 |
Evidence for mediation of acetyl glyceryl ether phosphorylcholine stimulation of adenosine 3',5'-(cyclic)monophosphate levels in human polymorphonuclear leukocytes by leukotriene B4.
Topics: Adenylyl Cyclases; Animals; Arachidonic Acid; Arachidonic Acids; Cyclic AMP; Enzyme Activation; Epinephrine; Humans; Kinetics; Leukotriene B4; Neutrophils; Platelet Activating Factor; Sodium Fluoride; Swine | 1983 |
Hypotensive and vasodilatory activity of (+/-) 1-o-octadecyl-2-acetyl glyceryl-3-phosphorylcholine in the normotensive rat.
Topics: Acetylcholine; Animals; Blood Pressure; Dose-Response Relationship, Drug; Histamine; Infusions, Intra-Arterial; Injections, Intravenous; Isoproterenol; Male; Platelet Activating Factor; Rats; Rats, Inbred Strains; Renin; Vasodilation | 1983 |
Studies on the stimulation of human blood platelets by semi-synthetic platelet-activating factor.
Topics: Adenosine Diphosphate; Arachidonic Acids; Blood Platelets; Calcimycin; Collagen; Dose-Response Relationship, Drug; Epinephrine; Humans; In Vitro Techniques; Platelet Activating Factor; Platelet Aggregation; Serotonin; Time Factors | 1983 |
Regulation of the oxidative burst of macrophages by lipid mediators.
Topics: Animals; Guinea Pigs; Lipids; Lipoxygenase; Lipoxygenase Inhibitors; Macrophages; Mice; Oxidation-Reduction; Platelet Activating Factor; Prostaglandins E | 1984 |
Inflammatory characteristics of platelet activating factor (PAF-acether) in human skin.
Topics: Adult; Dermatitis, Contact; Dinoprostone; Dose-Response Relationship, Drug; Double-Blind Method; Drug Synergism; Humans; Injections, Subcutaneous; Platelet Activating Factor; Prostaglandins E; Skin | 1984 |
Aortic vascular and atrial responses to (+/-)-1-O-octadecyl-2-acetyl-glyceryl-3-phosphorylcholine.
Topics: Animals; Aorta; Dose-Response Relationship, Drug; Heart Atria; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Platelet Activating Factor; Rats; Rats, Inbred Strains; Stimulation, Chemical | 1983 |
Effects of NaCl and GTP on the inhibition of platelet adenylate cyclase by 1-O-octadecyl-2-O-acetyl-sn-glyceryl-3-phosphorylcholine (synthetic platelet-activating factor).
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Animals; Blood Platelets; Guanosine Triphosphate; Humans; Platelet Activating Factor; Rabbits; Sodium Chloride | 1984 |
Cytotoxicity of platelet activating factor and related alkyl-phospholipid analogs in human leukemia cells, polymorphonuclear neutrophils, and skin fibroblasts.
Topics: Antineoplastic Agents; Cell Line; Cell Survival; Fibroblasts; Humans; Kinetics; L-Lactate Dehydrogenase; Leukemia; Neutrophils; Platelet Activating Factor; Serum Albumin, Bovine; Skin | 1984 |
Conversion of 3H-PAF acether by rabbit platelets is independent from aggregation: evidences for a novel metabolite.
Topics: Animals; Blood Platelets; Chromatography, Thin Layer; Kinetics; Platelet Activating Factor; Platelet Aggregation; Rabbits; Tritium | 1983 |
Activation of human and rabbit blood platelets by synthetic structural analogs of platelet activating factor.
Topics: Animals; Blood Platelets; Dose-Response Relationship, Drug; Humans; Platelet Activating Factor; Platelet Aggregation; Rabbits | 1983 |
Effect of synthetic PAF-acether on human neutrophil function.
Topics: Animals; Chemotactic Factors; Chemotaxis, Leukocyte; Complement System Proteins; Glucuronidase; Guinea Pigs; Humans; In Vitro Techniques; Interleukin-8; Lysophosphatidylcholines; Neutrophils; Platelet Activating Factor | 1981 |
Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: evidence for a platelet independent mechanism.
Topics: Animals; Cardiac Output; Coronary Circulation; Female; Kidney; Lysophosphatidylcholines; Male; Microspheres; Platelet Activating Factor; Rats; Rats, Inbred Strains; Regional Blood Flow; Spleen; Vascular Resistance | 1982 |
Variable responses of human platelets to synthetic platelet activating factor and their modification by epinephrine.
Topics: Dose-Response Relationship, Drug; Epinephrine; Female; Humans; Indomethacin; Male; Phentolamine; Platelet Activating Factor; Platelet Aggregation | 1982 |
New total synthesis and high resolution 1H NMR spectrum of platelet-activating factor, its enantiomer and racemic mixtures.
Topics: Animals; Blood Coagulation Factors; Lysophosphatidylcholines; Magnetic Resonance Spectroscopy; Platelet Activating Factor; Platelet Aggregation; Rabbits; Stereoisomerism | 1981 |
Platelet activating factor (PAF-acether): total synthesis of 1-O-octadecyl 2-O-acetyl sn-glycero-3-phosphoryl choline.
Topics: Indicators and Reagents; Lysophosphatidylcholines; Magnetic Resonance Spectroscopy; Methods; Platelet Activating Factor; Spectrophotometry, Infrared | 1980 |
Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant i
Topics: Animals; Azepines; Binding, Competitive; Guinea Pigs; In Vitro Techniques; Kinetics; Macrophages; Male; Peritoneal Cavity; Platelet Activating Factor; Platelet Membrane Glycoproteins; Radioligand Assay; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Respiratory Burst; Triazoles | 1993 |
Urinary promutagens of smokers: comparison of concentration methods and relation to cigarette consumption.
Topics: Cotinine; Female; Humans; Linear Models; Male; Mutagenicity Tests; Mutagens; Nicotiana; Nicotine; Plants, Toxic; Platelet Activating Factor; Polystyrenes; Resins, Synthetic; Salmonella typhimurium; Smoking; Tars; Urine | 1996 |
Platelet activating factor is elevated in cerebral spinal fluid and plasma of patients with relapsing-remitting multiple sclerosis.
Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Blood-Brain Barrier; Capillaries; Child; Disease Progression; Female; Gadolinium; Gas Chromatography-Mass Spectrometry; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Sclerosis; Platelet Activating Factor; Recurrence | 1999 |
Pharmacokinetic analysis of platelet-activating factor in the tears of guinea pigs with allergic conjunctivitis.
Topics: Animals; Conjunctivitis, Allergic; Eye; Guinea Pigs; Male; Ovalbumin; Platelet Activating Factor; Tears; Time Factors | 2006 |
Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.
Topics: Animals; Apoptosis; Carbon; Caspases; Cell Line; Cerebellum; Gene Expression Regulation; Mice; Micelles; Neurons; Neuroprotective Agents; Neurotoxins; Phospholipid Ethers; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, G-Protein-Coupled; Signal Transduction | 2008 |